Covid-19 roundup: No­vavax plots EU vac­cine ship­ments by end of year — re­port; Pfiz­er pledges med­i­cines, equip­ment to In­dia

With No­vavax near­ing a Phase III read­out for its re­com­bi­nant Covid-19 vac­cine, the Mary­land biotech will re­port­ed­ly be­gin ship­ping com­mer­cial dos­es to the EU bloc as ear­ly as the end of 2021 with a for­mal agree­ment in the off­ing, Reuters re­port­ed.

No­vavax will ship 200 mil­lion dos­es of its shot to the EU as part of a draft sup­ply deal signed in De­cem­ber de­spite the fact the vac­cine mak­er is still be­ing plagued by pro­duc­tion prob­lems, the out­let said, cit­ing an of­fi­cial fa­mil­iar with the dis­cus­sions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER